Home > Healthcare > Medical Devices > Medical Supplies > Biohazard Bags Market
Based on the capacity, the biohazard bags market value from the more than 35-gallon segment reached USD 200 million in 2022. Hazardous waste bags with a capacity of 35-gallons and over have a 1.2-millimeter liner low density, providing excellent puncture and tear resistance. Due to their thickness, these waste bags can reduce contamination risks during the disposal, treatment, and collection of medical waste, thereby increasing product acceptance in nursing centers, labs, and hospitals. Furthermore, the capability to carry heavy medical waste will stimulate the usage of these biohazard bags across healthcare facilities.
The polypropylene material segment accounted for more than 32.5% share of the biohazard bags market in 2022, owing to the product’s effectiveness in tubes, micro tips, and other light instrument disposals. Sample storage bags made of liner low-density PP can also withstand high-temperature sterilization and are easy to open, making them suitable for lightweight hazardous waste collection. In addition, the growing regulatory focus on the use of essential healthcare equipment such as autoclave machines for efficient waste treatment will also boost the requirement for PP autoclavable biohazard bags.
In terms of the end-use, the biohazard bags market share from the clinics and diagnostic centers segment is poised to depict an 8% CAGR through 2023-2032, on account of the rising emphasis on enhancing patient care through the expansion of healthcare facility networks. To cite an instance, in April 2022, Mayo Clinic announced USD 49 million in investment in a laboratory expansion project in Rochester. The rise in need for proper medical waste disposal at these facilities will therefore amplify the demand for biohazard bags.
The growing burden of chronic diseases will also accelerate medical waste generation and in turn, proliferate biohazard bag consumption across clinics and diagnostic centers. For instance, the recent COVID-19 outbreak led to a significant increase in the generation of medical waste in clinics and diagnostic facilities, further driving product consumption.
North America held over 40% share of the global biohazard bags market in 2022. The issuance of strict guidelines from government agencies including the U.S. CDC to ensure proper collection and disposal of healthcare waste is one of the key drivers impelling industry progress. As per the guidelines issued during the coronavirus outbreak, for instance, sharp medical waste was to be disposed of in red biohazard bags. Moreover, the introduction of regulatory policies to mitigate the impact of infectious diseases due to improper waste disposal will also drive product consumption across the region.